QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evercore-isi-group-maintains-outperform-on-thermo-fisher-scientific-lowers-price-target-to-600

Evercore ISI Group analyst Vijay Kumar maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and lowers the price ...

 barclays-maintains-equal-weight-on-thermo-fisher-scientific-lowers-price-target-to-600

Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Equal-Weight and lowers the price target ...

 sareptas-expanded-approval-unlikely-to-influence-novo-holdings-acquisition-of-catalent-but-provides-investor-protection-amid-uncertainty

Catalent shares rise after Sarepta Therapeutics' Elevidys expanded approval. Despite uncertainties, Catalent's risk/rew...

 morgan-stanley-fund-manager-advises-investors-to-diversify-amid-big-tech-frenzy-here-are-2-stocks-he-recommends

Aaron Dunn, a portfolio manager at Morgan Stanley, advised investors to diversify beyond the "Magnificent Seven" tech s...

 jefferies-assumes-thermo-fisher-scientific-at-buy-raises-price-target-to-650

Jefferies analyst Tycho Peterson assumes Thermo Fisher Scientific (NYSE:TMO) with a Buy rating and raises Price Target to $650.

 ultragenyx-faces-lawsuit-over-alleged-unjust-use-of-henrietta-lacks-cells

The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical over the use of HeLa cells taken wit...